R&D – media

Sanofi, Evotec in major infectious disease R&D transfer and license deal

Big Pharma Sanofi and German CRO-biotech drug discovery hybrid Evotec are penning a deal that will see Sanofi license out a host of infectious disease assets to the biotech, with 100 staffers also moving into its R&D engine.
- Source: Fiercebiotech
- 550
- March 12, 2018
infections Market Views R&D
Investors place bet on Chinese drugmakers

Chinese biotech groups are on target to raise about $10bn this year from venture capital funding, initial public offerings and licensing deals with overseas pharma companies, in what is partly a bet that Chinese-developed drugs can compete globally.
- Source: ft
- 877
- November 24, 2017
China drug innovation pharmaceutical R&D
Shooting for a new standard on osteoarthritis, Merck KGaA outlines promising data for a potential game-changer

Merck KGaA’s pharma group is taking one more step in a long journey toward rehabbing its rep in the R&D field this weekend. Company execs turned up at the ACR scientific conference in San Diego to roll out a promising look at some key Phase II osteoarthritis data — which comes with a critical caveat.
- Source: Endpts
- 651
- November 13, 2017
Merck osteoarthritis R&D sprifermin
Top 15 Companies

Medtronic top medtech R&D spender in 2022; Abbott to knock Johnson & Johnson off second place spot.
- Source: evaluategroup
- 1,240
- October 7, 2017
Market Reports R&D
Neuros Medical, Evolent Health, Osprey Medical

Deals are reached by Neuros Medical, Evolent Health and Osprey Medical last week.
- Source: medicaldevice-network
- 540
- August 14, 2017
Clinical R&D Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.